Hiramatsu Hiroaki

Research field (1)： Tumor biology

Research theme for competitive and other funds (4)：

2022 - 2025 Landscape of humoral immune system in patients with mature T-cell neoplasms, and its clinical application
2021 - 2024 変異型CCR4の分子動態の解明に基づく抗CCR4抗体治療法の革新
2021 - 2023 Establishment of the gene engineering T cell therapy enhancing the migration activity to cancer
2019 - 2021 Study of regulatory mechanisms of gene expression that determine immunosuppressive potential for application to cancer immunotherapy

Papers (1)：

Hiroaki Hiramatsu, Rui Yokomori, Liu Shengyi, Norio Tanaka, Seiichi Mori, Kazuma Kiyotani, Osamu Gotoh, Shigeru Kusumoto, Nobuaki Nakano, Youko Suehiro, et al. Clinical landscape of TP73 structural variants in ATL patients. Leukemia. 2023

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page